All News

Pharmapack Awards winners and industry leaders will meet up in a live webinar at CPHI Festival of Pharma to discuss the evolution of next-generation products in pharma packaging, administration & drug delivery devices.

Scientists at the University of Birmingham, UK have evaluated Sympfiny® as device for orally dispensing multiparticulate drugs to children aged 4-12.

Multiparticulates, an emerging technology with many advantages over traditional dosage forms are particularly suited for use in paediatric medicine. The Sympfiny® system is specifically tailored to administering multiparticulate drug formulations,...

There is a great focus on medical packaging as a means of protecting the drug, but there is still a long way to go when talking about the real needs of patients, and what packaging can do for them. For the past six years, Giana Carli Lorenzini,Postdoct...

Evive Biotech, a global biologics company developing novel biological therapies, is delighted to announce that its pivotal Phase III study (NCT03252431) for F-627 (efbemalenograstim alpha) to treat chemotherapy-induced neutropenia (CIN) in breast cance...

VAV Lipids announced that it has received written confirmation for their lecithin and phospholipids manufacturing facility at Ratnagiri, India pursuant to a successful inspection carried out by Indian CDSCO. The written confirmation is required fo...

The transaction will further complement and expand Mylan's complex injectables offering and presence in hospitals.

The company is already constructing a digital platform for the pharmaceutical industry that will utilize IoT devices and blockchain technology to link temperature control and other logistics information end-to-end.

Miami, FL/June 22, 2020 - Quotient Sciences, a global pharmaceutical development, clinical and commercial manufacturing organization, announced today the completion of a $1 million dollar pharmacy and laboratory expansion at their Miami, FL clinical ph...

The partnership will focus on developing multiple ADCs using Catalent’s proprietary SMARTag site-specific bioconjugation technology.

Hybrid clinical trials leveraging safety-focused, direct-to-consumer logistical solutions are taking center stage, ensuring research continuity.

THESS dispenser is equipped with an identity-vigilance system and warns patients when they need to take their treatment and verifies it has been delivered in accordance with the prescribed dose

The pandemic that has swept over the world in 2020 has caused huge disruption to the European pharmaceutical industry's regulatory procedures and supply chain management. But the crisis has also provided a platform for a learning process for the sy...

KOLINPHARMA® S.p.A. presents the new product IVUXUR® TABLETS, which is added to the other 9 patented or patent pending products, already present in the portfolio.

Bushu Pharmaceuticals Ltd., one of Japan's largest contract manufacturers of pharmaceutical products, announced a major capital program costing $100 million to expand its footprint, capacity and portfolio of services. The program extends over the next ...

Collaboration Expedites Human Clinical Trials for COVID-19 Drug Candidate. A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials was announced today [April 28, 2020] by Quotient Sciences, a lead...

CPHI & P-MEC India and Global Business Reports are pleased to bring you the Gujarat Pharma 2020 report, sharing our view on the most attractive opportunities in the Indian pharma market. The report provides an outlook for the Gujarat region in India as...

Best-in-class automation, robotics and state-of-the-art touchless production lines that provide the cleanliness required for parenteral packaging containers.

Trial enrolling up to 30,000 adults aged 18 years or over to assess safety, efficacy and immunogenicity of AZD1222 for the prevention of COVID-19.

An effective immune system is your best defense, and the right probiotics can help! The COVID-19 global crisis has led to a peak in demand for products able to stimulate immunity. Given the well-established importance of the microbiota in immune health...

GVK BIO, a leading global Contract Research and Development Organisation (CRDO), and BE Pharmaceuticals Inc (BE Inc), a rapidly growing pharmaceutical company that develops, manufactures and markets complex and critical injectable products, announced a...

GVK BIO, a leading global Contract Research and Development Organisation (CRDO), is pleased to announce the promotion of Sudhir Kumar Singh, Ph.D., to the position of Chief Operating Officer and the appointment of Ramesh Subramanian, Ph.D., as its new ...

Aragen Bioscience, Inc, a subsidiary unit of GVK BIO and one of the leading pre-clinical CRO specializing in monoclonal antibody and other large-molecule product development and Serum Institute of India Pvt. Ltd. (Serum), the world’s largest vaccine ma...

Aragen Bioscience is pleased to announce the appointment of Dr. Steven Lang as Vice President, Biologics. Aragen, a wholly-owned subsidiary of GVK BIO, is a leading Contract Research Organization focused on accelerating biologics product development wi...

Aragen Bioscience, Inc, a fully owned subsidiary of GVK BIO and a leading large molecule CRO, and University of Technology Sydney (UTS), the top-ranked young university in Australia, are pleased to announce a collaboration to accelerate biologics R&D i...

Full Service “Sequence-to-Manufacturing” Offering Designed to Drive Efficiencies and Reduce Overall Timelines for Delivering Early-Stage CGMP Bulk Drug Substances

Oragenics, Inc. (NYSE American: OGEN), (the “Company” or “Oragenics”), today announced, that through its wholly-owned subsidiary, Noachis Terra, it has entered into an agreement with Aragen Bioscience, a leading contract research organization focused o...

X 3 Tablet Press incorporates production capabilities and versatility traditionally limited to large-scale production machines.

Enzyme specialists from EUCODIS Bioscience and diagnostics experts from Biosynth-Carbosynth have teamed up to develop a novel diagnostic tool for the fast and reliable detection of an acute SARS-CoV-2 infection. Based on viral enzymatic activities and ...

Telecommuting and online commerce has been with us for some time and works seamlessly in many industries, but the current state of events has forced companies to apply remote management to other areas that have historically been considered "hands-on" j...

SGS is pleased to announce the signing of an agreement with AstraZeneca for the provision of safety, quality control and analytical testing services in support of AZD1222 – a COVID-19 vaccine candidate co-invented by the University of Oxford and its sp...

In a consortium led by the Jenner Institute, Oxford University, SGS has joined forces with specialists in infectious diseases, research and innovation, and pharmaceuticals to rapidly develop, scale-up and produce a potential vaccine called ChAdOx1 nCov...

Semglee available in vial and pen presentations at a 65% discounted list price, the lowest available for a long-acting insulin glargine on the market.

Ventofor Combi Fix delivered by the PowdAir Plus dry powder inhaler.

Bridgewest to develop the site into a full-service contract development and manufacturing organization.

Growing demand for pharma and biotech outsourcing presents a tremendous opportunity for CDMOs, but the impact of COVID-19 adds to a growing list of considerations for finding the right commercial partners to deliver critical medicines.  A recent C...

June 23rd, 2020: W. R. Grace & Co., a global leader in specialty silica, today announced the opening of its new 8,200 square-meter state-of-the-art, colloidal silica plant at its European flagship manufacturing and R&D center in Worms, Germa...

May 08, 2019, Hyderabad, India/California, US: GVK BIO is pleased to announce the appointment of  Dr. Axel Schleyer as Chief Executive Officer, Aragen Bioscience Inc.  

GVK BIO, a leading global Contract Research and Development Organisation (CRDO), and LifeArc, one of UK’s top medical research charities, are pleased to announce 

 GVK BIO, a leading global Contract Research and Development Organisation, announced today that United States Food and Drug Administration (FDA) has approved its cGMP Analytical Service Laboratory located at IDA, Mallapur Campus, Hyderabad. The in...

GVK BIO is pleased to announce the appointment of Dr. Robert (Bob) R. Ruffolo, to its Board of Directors.

Röchling Medical's innovative intelligent packaging solution against non-adherence.
Connect-e-Cap® Reminds patients of the next required doseRecords fill level, opening time etc.Recognizes the container via pairing functionReads o...

We are announcing a relocation...

Supply chain safety, quality and reliability are key to all our Quats and Insulin Human customers. Here is how we can help you secure your supply chain, from sourcing raw materials to delivering your products as promised – even in a global crisis.

Benzalkonium Chloride (BKC) is recommended by several national agencies as an effective agent to control infection by Covid-19.

Whether you are an employee, a manager or a business owner, we share a common goal – we don’t want anyone to get hurt on the job. Therefore, employee health and safety conditions are incorporated in all our work tasks.

In your quest to meet the regulatory requirements for your oral solids project, you may encounter significant hurdles. Anticipating these early on and thoroughly planning your approach can help. Experts in the Pfizer CentreOne global network, Gillian M...

In a compressed timeframe, producing large quantities of pharmaceutical glass containers to deliver the coronavirus vaccine around the world is a critical factor for a successful global response. Type 1 glass is a proven and widely available solution f...

Drugmakers are warning of a potential shortage of vials to bottle future COVID-19 vaccines, but their rush to secure supplies risks making matters worse, some major medical equipment manufacturers warn.

SGD Pharma, one of That's Nice's Road to 2021 sponsors, discusses how the company is innovating to face the challenges of the COVID-19 pandemic and beyond to face the future of healthcare.

As a key supplier to the global pharmaceutical industry, SGD Pharma is well versed in the process of contingency planning. This experience has greatly assisted the specialist glass packaging manufacturer in implementing its response to the Covid-...

The pharmaceutical packaging specialist is preparing to relaunch an investment plan of 37 million euros in its two French factories

Researchers have designed a simple, low-cost device for subcutaneous injection of viscous formulations.

Learn more on our unigel technology, platform for multi-purpose, multi-dose therapies in fixed dose combinations in softgels. Ready-to-market formulas available. 

The present is an overview of the state-of-the-art for vegetarian soft capsules in terms of materials (sourcing and demand), applications, processing, products and a general insight of the current state of materials and technology of these gelatin ...

Forbius's lead investigational asset, AVID200 holds promise as an effective and well-tolerated therapeutic in fibrotic diseases and immuno-oncology.

The CMO's new Chief Operating Officer will continue the company's operational response to COVID-19.

Global Pharma Insights speaks to Deepak Sapra, CEO of Active Pharmaceutical Ingredients and Services at Dr. Reddy's Laboratories, for his perspective on the current state of the Indian healthcare and pharmaceuticals sector

Amid concerns that global immunization programs may suffer from a shortage of vials to hold doses of approved vaccines against COVID-19, pharmaceutical packagers are busy ensuring they have the required capacity to meet the huge demand.

Dr. Reddy's Laboratories Ltd. announces partnering with FUJIFILM Corporation through FUJIFILM Toyama Chemical Co. Ltd.  and Global Response Aid for the development, manufacture and sales of Avigan® Tablets (generic name: favipiravir), a potentia...

The company will prepare the Harmans facility to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing later this year.

The company will target working with small and medium biotechs who require a science-driven, rather than a volume-driven partner.

The transaction will allow Takeda to focus on five key business areas.

This chart from investment advisory firm, Virtue Capital Partners Ltd, provides an up-to-date snapshot of how the US and the UK compare in terms of their respective investment in anti-COVID 19 vaccines and drugs, providing useful data such as number of...

Endotoxins or pyrogens are lipopolysaccharides – outer membrane components of gram-negative bacteria. During decomposition or metabolism, these bacteria release lipopolysaccharides, which are toxic. Parenteral-induced quantities as low as 0.1ng/kg of b...

An exclusive interview with Mr. Sudarshan Jain, Secretary-General, Indian Pharmaceutical Alliance

We have extended our #pharmaceutical #packaging competence to include cryptographic coding for the Russian market.  
Our lines as well as printing and camera control systems are equipped with the necessary add-ons, connection to exter...

3D printing technology has many potential advantages, such as reducing costs and speeding up manufacturing. But how suitable is it to enhancing pharmaceutical drug production?

Developments in smart packaging can add value to the pharmaceutical supply chain and help to tackle the threat of counterfeit products as the race towards producing a COVID-19 vaccine heats up Dr Alex Cole, Senior Strategic Marketing Manager, CPI

ANA Therapeutics, a Silicon Valley-based biotech startup, and Quotient Sciences, a leading provider of innovative drug development and manufacturing solutions, today announced a partnership to support the manufacturing of ANA Therapeutics’ drug candida...

This milestone secures future production of CombiGene's CG01 drug candidate to treat drug-resistant focal epilepsy.

Company working to ensure broad global access to COVID-19 vaccine candidate, following approval from regulators.

Dr. Paul Lohmann® has recently developed Iron(III) Polymaltose Complex and Iron(II) Bisglycinate as active pharmaceutical ingredients. These products are available including API documentation (DMF/ASMF) for the registration of a medicinal drug at the h...

One of India's fastest growing CDMOs goes "beyond the norm" to reinvent itself as a new generation global CDMO.

The transaction will enable Sanofi to expand and accelerate development of BTK inhibitors across multiple indications, including MS and other central nervous system diseases.

The instrument also tests ethanol and isopropanol concentrations to confirm product efficacy.

The free webinar investigates online training and how it can essentially optimize the tablet manufacturing process.

Atomwise technology removes the barriers of physical screening that have limited the success of traditional methods for small molecule drug discovery.

Details of new CPHI South East Asia Online Business Matchmaking Platform to be announced shortly.

The company is also scaling up its manufacturing capability with its partners — Lonza, Catalent and Rovi — should the vaccine get the green light.

The company has reserved one fill/finish line for the next 18 months to guarantee the supply of vaccines required to fight COVID-19 in the UK.

The world’s largest in-person pharma exhibition CPHI Worldwide has transformed into a unique digital experience and expo for 2020 to ensure that the industry can continue to connect, interact and learn despite current restrictions due to the ongo...

Customers in the region will have the opportunity to conduct laboratory-scale compression and coating trials, using automated coating equipment.

The extension will add a capacity of over 10 million doses per annum to the site.

New mid-scale microbial facility will support Servier with API for acute lymphoblastic leukemia therapies.

SPI Pharma has announced an expansion of its line of Mannogem Mannitol products for use in multiple patient-friendly oral dosage forms to now include: Mannogem XL Opal, Mannogem XL Ruby, Mannogem Emerald, and Mannogem Onyx. 

The company expects to manufacture the clinical-stage gene therapy product in its commercial-scale GMP manufacturing facilities.

Discussions relate to vaccine candidate using Sanofi’s recombinant protein-based technology combined with GSK’s pandemic adjuvant system.

The companies are set to manufacture globally up to 100 million doses by the end of 2020 and approximately 1.3 billion doses by the end of 2021.

Bendalis and Inceptua enter into an exclusive oncology medicine supply agreement for clinical trials

The transaction will enable the CDMO to offer plasmid production and end-to-end cell and gene therapy services.

The European Medicines Agency's human medicines committee (CHMP) has recommended the suspension of European marketing authorizations of generic medicines tested by Panexcell Clinical Laboratories at its site in Mumbai, India, citing irregularities in h...

The company will adapt its digital platform to digitize any COVID-19 antibody rapid test assay and embed this within an app available on smartphones and tablets.

The event organizers are working on preparing bespoke digital product offerings to help the market continue to meet, do business and exchange ideas later this year.

The $30 million investment will enable the site to handle large-molecule programs, with additional capacity for small molecule dosage form development.

The data generated through the partnership will help biopharma companies to develop robust manufacturing processes and minimize challenges during scale-up and commercialization.

Acryl-EZE formulations provide significant time savings and targeted drug delivery.

Data on the first clinical use of lenzilumab in patients with severe COVID-19 pneumonia suggest promising results.

Watson-Marlow's new Certa Plus sinusoidal pump provides a sustainable solution for shear sensitive, viscous pharmaceutical products.

Sterile transfer solutions without compromising operational efficiency.

Junshi Biosciences cites Lonza’s GS Xceed gene expression system as a critical enabler for the program.

Our Process Chemistry R&D laboratory at Alderley Park, Manchester is now open for business. Feel free to reach out to us for all your process development needs. Refer this link for information on our new lab.

The company is also involved in projects that aim to enable population-level screening for the current coronavirus.

Further milestone paves the way for production of novel gene therapy drug candidate designed to treat drug-resistant focal epilepsy.

The center will host a new BioReliance End-to-End Solutions GMP manufacturing facility offering CDMO services to customers in China and Asia-Pacific.

The agreement is aimed at helping to reduce essential drug shortages in the US

Our first in a series of monthly podcasts looks back at the key points covered in five webinars we hosted in May showcasing the pharma industry's response to the COVID-19 pandemic

In this podcast, Global Pharma Insights speaks to Stefan Schmidinger, Partner at Kemiex AG on how trading and procurement of active pharmaceutical ingredients has been affected by the global coronavirus pandemic

The company began scaling up manufacturing of REGN-COV2 at business risk earlier this year to ensure the immediate availability of the product if clinical trials prove successful.

The CRO will undertake this clinical trial at multiple sites worldwide, starting at the AZ Sint Maarten hospital in Mechelen, Belgium.

Companies agree that the key to tackling drug development complexity is collaboration.

The transaction will more than double Croda’s R&D capability in drug delivery.

Following on from the success of the inaugural iPitch launch in 2019, iNova Pharmaceuticals is delighted to announce the launch of a new round of iPitch challenges for 2020.

Data is the bedrock of a pharmaceutical product’s pathway to market, and the consequences of data failures can be immense. What can companies do to ensure they overcome data integrity challenges?

Two company sites - one in Canada, the other in Brazil - receive new softgel encapsulation lines to service local customer demand.

The 10-day event will feature an interactive digital marketplace for sourcing products and services, enhanced matchmaking for connecting with new and existing partners, and world-renowned speakers.

AJILITY is designed to speed novel or existing therapeutics from development to manufacturing and into the clinic.

SeaGel offers drug and dietary supplement manufacturers an animal-free and sustainable alternative to traditional soft capsules.

The global outsourcing solutions provider is also set to expand its biotech capabilities in Europe.

The prefilled pen supports more convenient self-administration for patients with chronic type 2 inflammatory diseases.